Viamet Pharmaceuticals Inc., a Research Triangle Park, N.C.-based biotech company targeting metalloenzymes, has raised $4 million in Series A funding. Hatteras Venture Partners and seed backer Intersouth Partners co-led the deal. www.viamet.com
Viamet Raises $4 Million
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.